Prothena Corporation plc (NASDAQ:PRTA) Q4 2024 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the Prothena Biosciences Fourth Quarter and Full Year 2024 Financial Results Conference Call.
Prothena Corp Public Ltd Co (PRTA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | EcoR1 Capital Oleg Nodelman | 11,584,280 | $160,442,278 | 6.06% | |
| 2. | Armistice Capital Steven Boyd | 2,236,000 | $30,968,600 | +36% | 0.42% |
| 3. | Palo Alto Investors William Leland Edwards | 1,737,964 | $24,070,801 | 3.72% | |
| 4. | Siren L.L.C. Raymond Debbane | 1,099,840 | $15,232,784 | 0.67% | |
| 5. | Boxer Capital Aaron Davis And Christopher Fuglesang | 690,000 | $9,556,500 | 0.81% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $37.50 | 300,000 | Large Shareholder | 11,584,280 | 2022-01-12 | Filing | |
| $20.75 | 875,000 | Large Shareholder | 11,034,280 | 2021-03-24 | Filing | |
| $22.02 | 10,800 | Large Shareholder | 10,159,280 | 2021-02-24 | Filing | |
| $21.05 | 44,400 | Large Shareholder | 10,148,480 | 2021-02-23 | Filing | |
| $23.65 | 44,100 | Large Shareholder | 10,104,080 | 2021-02-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $34.00 | 5,000 | 0 | 2024-01-24 | Filing | ||
| $37.45 | 3,322 | 0 | 2023-12-20 | Filing | ||
| $36.68 | 1,678 | 3,322 | 2023-12-20 | Filing | ||
| $34.00 | 5,000 | 0 | 2023-11-30 | Filing | ||
| $42.28 | 294 | 0 | 2023-10-25 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 88,339 | $1,093,195 | 0.39% | |
| 2. | 77,637 | $960,758 | 0.04% | |
| 3. | 66,079 | $817,714 | 0% | |
| 4. | 19,471 | $240,955 | 0.19% | |
| 5. | 2,018 | $24,973 | 0.01% |
News See All
7 Best Debt Free Stocks To Buy
Debt has always been the fuel driving many companies in the equity markets.
Prothena Corporation plc (NASDAQ:PRTA) Q4 2023 Earnings Call Transcript
Prothena Corporation plc misses on earnings expectations. Reported EPS is $-1.26 EPS, expectations were $-1.23.
Prothena Corporation plc (NASDAQ:PRTA) Q4 2022 Earnings Call Transcript
Operator: Good afternoon. My name is Audra and I will be your conference operator today.
10 Biotech Stocks to Buy According to Matthew Strobeck's Birchview Capital
In this article, we discuss 10 biotech stocks to buy according to Matthew Strobeck's Birchview Capital.
Hedge Funds Are Crazy About Prothena Corporation plc (PRTA)
In this article we will take a look at whether hedge funds think Prothena Corporation plc (NASDAQ:PRTA) is a good investment right now.
5 Reddit Stocks that Tripled in 2021
Houghton Mifflin Harcourt Company (NASDAQ:HMHC) is an education services firm based in Boston.
Do Hedge Funds Love Prothena Corporation plc (PRTA)?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Hedge Fund and Insider Trading News: Anthony Scaramucci, Paul Tudor Jones, Marshall Wace, Tiger Global Management, Gordian Capital, Mueller Industries, Inc. (MLI), Snowflake Inc (SNOW), and More
Hedge fund investor Anthony Scaramucci argues anyone who studies bitcoin carefully and understands the cryptocurrency will be convinced of its potential.
5 Pharmaceutical Stocks to Buy According to Lawrence Hawkins' Prosight Capital
In this article, we discuss 5 pharmaceutical stocks to buy according to Lawrence Hawkins' Prosight Capital.
Billionaire Hedge Funds
